Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Doherty

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Biorxiv : the Preprint Server for Biology|May 4, 2026
Transcriptomic subtypes in high-grade serous ovarian cancer are driven by tumor cellular compositionStephanie Tanis, Manoel Lixandrao, Adriana Ivich, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 23, 2021
Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of ProgestinsMinh Tung Phung, Alice W Lee, Anna H Wu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 4, 2022
Racial Differences in the Tumor Immune Landscape and Survival of Women with High-Grade Serous Ovarian CarcinomaLauren C Peres, Christelle Colin-Leitzinger, Sweta Sinha, et al.
Fertility and Sterility|October 1, 2022
Effects of risk factors for ovarian cancer in women with and without endometriosisMinh Tung Phung, Aruna Muthukumar, Britton Trabert, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 22, 2022
Reproductive Factors Do Not Influence Survival with Ovarian CancerMinh Tung Phung, Aliya Alimujiang, Andrew Berchuck, et al.
Cancer Science|December 17, 2017
Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association ConsortiumTomotaka Ugai, Linda E Kelemen, Mika Mizuno, et al.
Gynecologic Oncology|November 15, 2021
Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer associationLilah Khoja, Rachel Palmieri Weber, , et al.
Epidemiology (Cambridge, Mass.)|February 7, 2020
Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer: A Complicated Relationship ExploredAlice W Lee, Anna H Wu, Ashley Wiensch, et al.
Journal of the National Cancer Institute|July 12, 2023
A framework for assessing interactions for risk stratification models: the example of ovarian cancerMinh Tung Phung, Alice W Lee, Karen McLean, et al.
Plos One|February 25, 2011
The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white womenGalina Lurie, Mia M Gaudet, Amanda B Spurdle, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Biorxiv : the Preprint Server for Biology|May 4, 2026
Transcriptomic subtypes in high-grade serous ovarian cancer are driven by tumor cellular compositionStephanie Tanis, Manoel Lixandrao, Adriana Ivich, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 23, 2021
Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of ProgestinsMinh Tung Phung, Alice W Lee, Anna H Wu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 4, 2022
Racial Differences in the Tumor Immune Landscape and Survival of Women with High-Grade Serous Ovarian CarcinomaLauren C Peres, Christelle Colin-Leitzinger, Sweta Sinha, et al.
Fertility and Sterility|October 1, 2022
Effects of risk factors for ovarian cancer in women with and without endometriosisMinh Tung Phung, Aruna Muthukumar, Britton Trabert, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 22, 2022
Reproductive Factors Do Not Influence Survival with Ovarian CancerMinh Tung Phung, Aliya Alimujiang, Andrew Berchuck, et al.
Cancer Science|December 17, 2017
Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association ConsortiumTomotaka Ugai, Linda E Kelemen, Mika Mizuno, et al.
Gynecologic Oncology|November 15, 2021
Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer associationLilah Khoja, Rachel Palmieri Weber, , et al.
Epidemiology (Cambridge, Mass.)|February 7, 2020
Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer: A Complicated Relationship ExploredAlice W Lee, Anna H Wu, Ashley Wiensch, et al.
Journal of the National Cancer Institute|July 12, 2023
A framework for assessing interactions for risk stratification models: the example of ovarian cancerMinh Tung Phung, Alice W Lee, Karen McLean, et al.
Plos One|February 25, 2011
The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white womenGalina Lurie, Mia M Gaudet, Amanda B Spurdle, et al.
Pageof 6